ARTICLE | Clinical News
Pentasa mesalamine regulatory update
August 30, 2010 7:00 AM UTC
FDA denied Shire's request in a Citizen's Petition that generic formulations of its Pentasa controlled-release mesalamine capsules to treat ulcerative colitis be required to conduct studies with clini...